•  
  •  
  •  
  •  

2025-05-18 17:03:37

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Solitaire Machine Tools Limited recommends final dividend of Rs. 2
  • Divi's Laboratories Limited recommends final dividend of Rs. 30
  • BMW Industries Ltd recommends final dividend of Rs. 0.43
  • Fire accident at VIP Industries Ltd's warehouse
  • Baazar Style Retail Limited opens new Express Baazar store at Ranaghat

Keywords Selected:  Pharmaceuticals

Research

  • CRISIL: Pharmaceutical sector set for 8-10% revenue growth this fiscal
  • Kotak Institutional Equities - Pharmaceuticals: IPM pulse - gaining momentum
  • Company Update - P&G Health - ICICI Direct
  • Quant Pick - Cadila Healthcare - ICICI Direct
  • Q2FY22 Result Update - Syngene International - ICICI Direct
  • Syngene International Ltd - Lack of near term triggers - YES Securities
  • Syngene International Ltd - Lower gross margin lead to EBIDTA miss - YES Securities

IPO News

  • Accretion Pharmaceuticals' IPO Opens for subscription today, Price Band set at ₹96-101 per Share
  • Accretion Pharmaceuticals Ltd IPO to open for subscription on May 14, 2025
  • Senores Pharmaceuticals IPO subscribed 13.93 times on Day 2
  • Senores Pharmaceuticals IPO fully subscribed on Day 1
  • Senores Pharmaceuticals gets Sebi nod for IPO

Stock Report

  • Divi's Laboratories Limited recommends final dividend of Rs. 30
  • Jubilant Pharmova Limited recommends final dividend of Rs. 5
  • IOL Chemicals and Pharmaceuticals Ltd consolidated Q4 FY2025 net profit higher at Rs. 31.42 crores
  • Punita Lal Joins Lupin Board as Additional Director
  • Abbott India Limited recommends final dividend of Rs. 475
  • Neuland Laboratories Ltd recommends final dividend of Rs. 12
  • Kopran Ltd recommends dividend of Rs. 3
  • Caplin Point Laboratories Limited declares interim dividend of Rs. 3
  • Lupin receives approval from U.S. FDA for Rivaroxaban Tablets USP, 10 mg, 15 mg, and 20 mg
  • Alembic Pharmaceuticals receives USFDA Final Approval for Rivaroxaban Tablets USP, 2.5 mg, 10 mg, 15 mg and 20 mg
  • Senores Pharmaceuticals Ltd consolidated Q4 FY2024-25 profit declines to Rs. 17.83 crores
  • Lupin Ltd recommends dividend of Rs. 12
  • Piramal Pharma Limited recommends final dividend of Rs. 0.14
  • Shilpa Pharma Lifesciences Limited, Unit-1, Received EIR from USFDA
  • Mercury Laboratories Limited recommends final dividend of Rs. 3.50
  • Hikal Ltd recommends final dividend of Rs. 0.80
  • Blue Jet Healthcare Limited recommends final dividend of Rs. 1.2
  • Zydus receives EIR for the Ambernath API manufacturing facility
  • Shelter Pharma Ltd launches Three New Products
  • Caplin Steriles Ltd receives USFDA final approval for ANDA Haloperidol Decanoate Injection
  • J B Chemicals and Pharmaceuticals Ltd reports consolidated Q4FY25 PAT of Rs. 145.69 crores
  • Bharat Parenterals Limited recommends final dividend of Rs. 1
  • Morepen Laboratories Limited approves final dividend of Rs. 0.20
  • Wanbury's Tanuku facility granted Good Manufacturing Practices Certificate by ANVISA

Industry News

  • NYSE Listed Amneal Pharmaceuticals begins Commercial Operations in India

Latest Post

  • Solitaire Machine Tools Limited recommends final dividend of Rs. 2
  • Divi's Laboratories Limited recommends final dividend of Rs. 30
  • BMW Industries Ltd recommends final dividend of Rs. 0.43
  • Fire accident at VIP Industries Ltd's warehouse
  • Baazar Style Retail Limited opens new Express Baazar store at Ranaghat


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024